Predictions
ElringKlinger AG
Start price
Target price
Perf. (%)
€10.08
11.11.20
11.11.20
€12.00
3.57%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Aurelius AG
Start price
Target price
Perf. (%)
€15.96
10.11.20
10.11.20
-
10.11.21
10.11.21
15.91%
21.01.21
21.01.21
Future proof or reliable business model
Higher risks for its business
Little known brand
ElringKlinger AG
Start price
Target price
Perf. (%)
€8.78
10.11.20
10.11.20
€9.00
15.26%
11.11.20
11.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Stable Large shareholder and/or long term investor
Curevac N.V.
Start price
Target price
Perf. (%)
€50.44
10.11.20
10.11.20
€55.00
4.48%
12.11.20
12.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€48.01
10.11.20
10.11.20
€55.00
5.07%
10.11.20
10.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Nidec Corp.
Start price
Target price
Perf. (%)
€94.56
09.11.20
09.11.20
€105.00
2.18%
25.11.20
25.11.20
Future proof or reliable business model
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€18.34
08.11.20
08.11.20
-
0.55%
14.11.20
14.11.20
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.15
08.11.20
08.11.20
€5.00
08.11.21
08.11.21
-29.28%
09.11.21
09.11.21
Could be worthwhile Investment >10% per year
Bellicum Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.30
07.11.20
07.11.20
-
07.11.21
07.11.21
15.65%
15.07.21
15.07.21
Probably not worthwhile Investment
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€5.80
07.11.20
07.11.20
-
07.11.21
07.11.21
-0.34%
15.07.21
15.07.21
Could be very worthwhile Investment >20% year
Sfc Energy AG
Start price
Target price
Perf. (%)
€14.64
05.11.20
05.11.20
-
05.11.21
05.11.21
14.21%
18.01.21
18.01.21
Outdated or very high risk business model
High risks for its business
Risky Investment
Oncternal Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.50
05.11.20
05.11.20
-
05.11.21
05.11.21
47.44%
06.11.21
06.11.21
Sio Gene Therapies Inc.
Start price
Target price
Perf. (%)
€1.87
05.11.20
05.11.20
€2.00
05.11.21
05.11.21
-7.97%
06.11.21
06.11.21
Future proof or reliable business model
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€2.26
04.11.20
04.11.20
€3.20
04.11.21
04.11.21
-43.45%
10.07.21
10.07.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Nidec Corp.
Start price
Target price
Perf. (%)
€90.84
04.11.20
04.11.20
€100.00
4.10%
09.11.20
09.11.20
Future proof or reliable business model
WAVE Life Sciences Ltd
Start price
Target price
Perf. (%)
€6.40
04.11.20
04.11.20
-
-9.38%
07.11.20
07.11.20
Could be very worthwhile Investment >20% year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.45
03.11.20
03.11.20
-
04.11.21
04.11.21
136.51%
15.01.21
15.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.53
03.11.20
03.11.20
€10.50
04.11.21
04.11.21
51.47%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Kandi Technologies Corp.
Start price
Target price
Perf. (%)
€5.77
02.11.20
02.11.20
€4.90
04.11.21
04.11.21
-32.99%
01.11.21
01.11.21
EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
Misonix Inc.
Start price
Target price
Perf. (%)
€9.55
02.11.20
02.11.20
€11.00
04.11.21
04.11.21
4.19%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€11.40
02.11.20
02.11.20
€13.00
04.11.21
04.11.21
15.79%
16.11.20
16.11.20
Could be worthwhile Investment >10% per year